Kedrion Biopharma
Paola Grisetti has a rich and diverse work experience spanning several decades. paola started their career as a project manager at Foster Wheeler in 1989 and held this position until 2015. In 2015, they joined Bracco imaging S.p.A. as the Global Engineer Director, responsible for Global Technical Operations. After four years, they moved to Kedrion Biopharma in 2019, where they served as the Global Engineering Services Director. Currently, they are the Head of Corporate Engineering at Chiesi Farmaceutici S.p.A.
Paola Grisetti obtained a Laurea Magistrale LM in Ingengeria Gestionale from Politecninco Milano, having attended the institution from 1985 to 1989.
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.